Buy Lansoprazole DR from Canada

$249.99

Lansoprazole DR is engineered to resist the immediate acidic environment of the stomach. This mechanism allows the granules to pass intact through the stomach and release the active compound in the higher pH environment of the intestines. This targeted release is instrumental in ensuring that lansoprazole effectively inhibits the acid-producing proton pumps for an extended period, offering more sustained relief and promoting healing in acid-related conditions.

- +
Compare
Category:

Description

Lansoprazole delayed-release (DR) is a medication in the class of proton pump inhibitors (PPIs) specifically formulated to provide a sustained-release effect, thereby prolonging its action. It is commonly utilized for the treatment of conditions that benefit from the reduction of gastric acid over an extended period, such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. When compared to immediate-release formulations, delayed-release lansoprazole can maintain a consistent suppression of gastric acid over a longer duration, optimizing therapeutic benefits.